Eric Bao serves as the Finance Director and CFO for Greater China at Galderma, where he leverages over 18 years of extensive financial expertise across various sectors, including pharmaceuticals, FMCG, medical devices, financial consulting, and venture capital. With more than 12 years in his current...
Eric Bao serves as the Finance Director and CFO for Greater China at Galderma, where he leverages over 18 years of extensive financial expertise across various sectors, including pharmaceuticals, FMCG, medical devices, financial consulting, and venture capital. With more than 12 years in his current role, Eric has successfully led a team of around 20 finance professionals, driving strategic financial planning and managerial finance initiatives that align with Galderma's overarching business objectives.
In his capacity as the head of finance, Eric plays a pivotal role in shaping the financial landscape of Galderma in the Greater China region. His responsibilities encompass a broad spectrum of financial management activities, including financial reporting, auditing, and forecasting. Eric's deep understanding of the pharmaceutical industry allows him to navigate complex regulatory environments and market dynamics, ensuring that Galderma remains competitive and compliant. He is particularly adept at mergers and acquisitions, having led several successful integrations that have bolstered the company's market position.
Eric's passion for the healthcare and FMCG sectors drives his commitment to innovation and excellence in financial practices. His strategic insights and ability to synthesize data into actionable plans have been instrumental in optimizing resource allocation and enhancing profitability. As a forward-thinking leader, Eric Bao continues to foster a culture of collaboration and accountability within his team, positioning Galderma for sustained growth and success in the rapidly evolving landscape of the Greater China market.
